Treatment outcome of new culture positive pulmonary tuberculosis in Norway

BMC Public Health

Volumn 5, Issue , 2005, Pages

  Farah, Mohamed Guled ^a,b   Tverdal, Aage ^a   Steen, Tore W ^c   Heldal, Einar ^a   Brantsaeter, Arne B ^a   Bjune, Gunnar ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Health and Welfare Agency   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; LOGISTIC REGRESSION ANALYSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; NORWAY; REGISTER; RISK FACTOR; TREATMENT OUTCOME; ANTIBIOTIC RESISTANCE; DRUG COMBINATION; DRUG EFFECTS; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PATIENT COMPLIANCE; PRESCHOOL CHILD; TREATMENT FAILURE; TUBERCULOSIS, PULMONARY;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; ISONIAZID; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NORWAY; PATIENT COMPLIANCE; PYRAZINAMIDE; REGISTRIES; RIFAMPIN; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY;

EID: 15244356164     PISSN: 14712458     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-5-14     Document Type: Article

References (23)

1. World Health Organization: WHO Tuberculosis Programme: Framework for Effective Tuberculosis Control. Geneva, Switzerland: WHO/ TB/ 94. 179.
2. Zellweger JP, Coulon P: Outcome of patients treated for tuberculosis in Vaud County, Switzerland. Int J Tuberc Lung Dis 1998, 2:372-377.
3. Romanus V, Julander I, Blom-Bulow B, Larsson LO, Normann B, Boman G: Shortages in Swedish tuberculosis care. Good results only in 71 percent of cases after 12-month treatment as shown in a current study [in Swedish]. Läkartidningen 2000, 97:5613-5616.
4. Grzybowski S, Enarson DA: The fate of cases of pulmonary tuberculosis under various treatment programmes. Bull Int Union Tuberc 1978, 53:70-75.
5. Winje BA, Heldal E: Tuberculosis Disease in Norway 2002 [in Norwegian]. In MSIS-rapport No. 23 Oslo: Norwegian Institute of Public Health; 2003.
6. Heldal E: Results of tuberculosis treatment in Norway 1995 [in Norwegian]. Nor J Epidemiol 1997, 7:231-233.
7. Broekman JF, Migliori GB, Rieder HL, Lees J, Rutuu P, Loddenkemper R, Raviglione MC: European framework for tuberculosis control and elimination in countries with a low incidence. Eur Respir J 2002, 19:765-775.
8. Heldal E: Notification of tuberculosis in Norway [in Norwegian]. Nor J Epidemiol 1995, 5:15-17.
9. Bjartveit K: The control of tuberculosis. A handbook for community health service [in Norwegian]. Oslo: National Health Screening Service and Norwegian Board of Health; 1996.
10. World Health Organization: Global Tuberculosis Control. WHO Report 1999. Geneva, Switzerland, WHO/CDS/CPC/TB/99.259
11. The Norwegian Institute of Public Health: Manual of tuberculosis control and prevention in Norway [in Norwegian]. Oslo: The Institute; 2002.
12. Diel R, Nieman S: Outcome of tuberculosis treatment in Hamburg: a survey, 1997-2001. Int J Tuberc Lung Dis 2003, 7:124-131.
13. Dahle UR, Sandven P, Heldal E, Caugant DA: Molecular epidemiology of Mycobacterium tuberculosis in Norway. J Clin Microbiol 2001, 39:1802-1807.
14. The Royal Ministry of Health: The Control of tuberculosis [in Norwegian]. Oslo:The Ministry; 2002.
15. Fielder JF, Chaulk CP, Dalvi M, Gachuhi R, Comstock GW, Sterling TR: A high tuberculosis case-fatality rate in a setting of effective tuberculosis control: Implications for acceptable treatment success rates. Int J Tuberc Lung Dis 2002, 6:1114-1117.
16. Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M, Zalesky R: Standardized tuberculosis treatment outcome monitoring in Europe. Eur Respir J 1998, 12:505-510.
17. American Thoracic Society and Center for Disease Control and Prevention: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000, 161:221-247.
18. Naalsund A, Heldal E, Johansen B, Kongerud J, Boe J: Deaths from pulmonary tuberculosis in low-incidence country. Journal of Internal Medicine 1994, 236:137-142.
19. Rieder LH, Bloch AB, Snider DE: Tuberculosis diagnosed at death in the United States. Chest 1991, 100:678-681.
20. Xie HJ, Enarson DA, Chao CW, Allen EA, Grzybowski S: Deaths in tuberculosis patients in British Columbia, 1980-1984. Tuber Lung Dis 1992, 73:77-82.
21. Zafran N, Heldal E, Pavlovic S, Vukovic D, Boe J: Why do our patients die of active tuberculosis in the era of effective therapy? Tuberc Lung Dis 1994, 75:329-333.
22. Heldal E, Dahle UR, Sandven P, Caugant DA, Brattaas N, Waaler HT, Enarson DA, Tverdal A, Kongerud J: Risk factors for recent transmission of Mycobacterium tuberculosis. Eur Respir J 2003, 22:637-642.
23. Nolan CM, Goldberg SV: Treatment of Isoniazid-resistant tuberculosis with isoniazid, rifampicin, ethambutol and pyrazinamide for 6 months. Int J Tuberc Lung Dis 2002, 6:952-958.